BioSpace News Archive

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today has announced that it received Health Canada approval for the MANTA ® Vascular Closure Device.

AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that Josh Parnes, President and Director, and Jason Clemens, CFO, will participate in a fireside chat at the UBS Global Healthcare Conference 2022.

Ryvu Therapeutics (WSE: RVU), a clinical-stage drug discovery and development company focusing on novel small molecule therapies that address emerging targets in oncology, today reported financial results for the first quarter of 2022 and provided a corporate update.

China SXT Pharmaceuticals, Inc., a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces, including Advanced TCMPs, fine TCMPs, regular TCMPs, and TCM Homologous Supplements announced that an 1 for 20 reverse split of its ordinary shares was approved by the Company’s board of directors on May 10, 2022 and became effective on May 17, 2022.

Abivax SA, a clinical-stage biotechnology company developing novel therapies that modulate the immune system to treat chronic inflammatory diseases, viral infections, and cancer, informs its shareholders that its ordinary and extraordinary general meeting will be held on June 9, 2022, at 10:00 a.m., at the offices of Dechert LLP, located at 32 rue de Monceau in Paris, France.

Premier Medical Laboratory Services (PMLS) is announcing today that they have added Noninvasive Prenatal Testing (NIPT) to their full line of medical diagnostic testing and risk screening services.

Zentalis Pharmaceuticals, Inc. announced the closing of an underwritten offering of 10,330,000 shares of its common stock at an offering price of $19.38 per share, for total gross proceeds of approximately $200.2 million, before deducting underwriting discounts and commissions and offering expenses payable by Zentalis.

The Global Asthma Diagnostics Market was valued at US$ 3,385.5 Mn in 2021 and is forecasted to reach US$ 5,857.7 Mn by 2030, registering a CAGR of 6.5% over the projection period.

Sensus Healthcare, Inc. announces that management will be participating in the H.C. Wainwright Global Investment Conference taking place virtually and in-person at the Fontainebleau Miami Beach May 23-26, 2022.

Vir Biotechnology, Inc. (Nasdaq: VIR) today reminds stockholders that it will hold its 2022 Annual General Meeting of Stockholders on Friday, May 20, 2022, at 11:30 a.m. PT.